Esperion Therapeutics reported $82.28M in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Alnylam Pharmaceuticals ALNY:US $ 657.68M 51.72M
Amarin AMRN:US $ 361.57M 61M
Amgen AMGN:US $ 12618M 268M
Biogen BIIB:US $ 5018M 1071.4M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Cytokinetics CYTK:US $ 66.84M 0M
Daiichi Sankyo 4568:JP Y 406816M 11548M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Esperion Therapeutics ESPR:US $ 82.28M 3.19M
Geron GERN:US $ 46.88M 0.25M
Halozyme Therapeutics HALO:US $ 199.51M 87.82M
Heron Therapeutics HRTX:US $ 109.5M 16.5M
Intercept Pharmaceuticals ICPT:US $ 151.43M 0.39M
Intra Cellular Therapies ITCI:US $ 70.63M 11.56M
IONIS PHARMACEUT IONS:US $ 267.81M 39.36M
Minerva Neurosciences NERV:US $ 3.41M 0.16M
Moderna Inc MRNA:US 6.81B 2.43B
Nektar Therapeutics NKTR:US $ 104.98M 0.3M
Ptc Therapeutics PTCT:US $ 567.37M 90.6M
Puma Biotechnology PBYI:US $ 56.83M 17.95M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Seattle Genetics SGEN:US $ 608.52M 77.23M
United Therapeutics UTHR:US $ 331.5M 38.9M
Vanda Pharmaceuticals VNDA:US $ 88.4M 2.34M